Clinical Trial: A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07803744) titled 'A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity' on Sept. 01.

Brief Summary: The main purpose of this study is to learn more how tirzepatide affects stomach emptying in participants with Type 1 Diabetes Mellitus (T1DM) and overweight or obesity.

Participation in this study will last about 8 weeks, including screening and follow-up.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus, Type 1 Overweight Obesity

Intervention: DRUG: Tirzepatide

Administered SC.

DRUG: Acetaminophen

Administered orally.

DRUG: Placebo

Administered SC. ...